Prices of Canadian generic medicines below international average

29 May 2019 - PMRPB: Canadian price declines steepest of all OECD countries. ...

Read more →

Feilding woman nervous about PHARMAC's decision to change epilepsy medication brands

28 My 2019 - Judy Lawrence recalls vividly the day she suffered a seizure walking down the stairs eight years ...

Read more →

Concerns over single brand move for epilepsy sufferers

16 April 2019 - Epilepsy New Zealand is raising concerns about PHARMAC changing its funding to just a single brand of ...

Read more →

Ontario may lift ban preventing major pharmacies from selling private-label generic drugs

21 March 2019 - Ontario Premier Doug Ford’s government is considering lifting a ban that prevents major pharmacy chains from ...

Read more →

Brexit contributes to surge in generic drug prices

13 December 2018 - Calls for government to protect pharmacies. ...

Read more →

Decision to remove funding restrictions for alendronate 70 mg products, decrease price, and award sole supply

30 November 2018 - PHARMAC is pleased to announce that the funding restrictions on alendronate 70 mg products will be ...

Read more →

Proposal to award sole supply and change some anti-retroviral brands

16 October 2018 - PHARMAC is seeking feedback on a proposal to make several changes to funding of anti-retroviral therapies ...

Read more →

NHS saved £324 million by switching to biosimilars and generics

2 August 2018 - The UK’s national healthcare provider saved £324 million by switching its patients to “better value” biosimilar ...

Read more →

Notification of dates for entecavir brand switch

9 July 2018 - PHARMAC has announced the listing date and transition timeframes for a brand switch for entecavir from ...

Read more →

New uses for old drugs

26 June 2018 - Low cost generics are an untapped source of therapeutic innovation. ...

Read more →

Canada's drug shortage problem needs action, say medical experts

5 June 2018 - Drug shortages in Canada are a problem in need of immediate solutions, according to a new ...

Read more →

Decision to remove restrictions from, and award a tender to, candesartan cilexetil

31 May 2018 - PHARMAC is pleased to announce a decision to remove the funding restrictions on candesartan cilexetil, in ...

Read more →

ACCC loses appeal against Pfizer over Lipitor sales

25 May 2018 - A court has dismissed an Australian Competition and Consumer Commission appeal in a case in which ...

Read more →

Fight over PHARMAC's switch to generic anti-depressant brand continues

27 April 2018 - Depression sufferers wanting to remain on old anti-depressant brand can – but at a cost. ...

Read more →

Prices of generic prescription drugs fall by 25-40%

3 April 2018 - Lower prices expected to save public drug plans up to $3 billion over next 5 years. ...

Read more →